Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000341265

Medchemexpress LLC p-Tolylmaleimide | 1631-28-3 | 98.0% | 100 MG
SDP

Catalog No. 5000341265
Encompass_Preferred

p-Tolylmaleimide (compound 9) is a naphthalimide derivative with cytotoxic effects on cancer cells. It can arrest the cell cycle of human acute myeloid leukemia cells K562 in the sub-G0/G1 phase and induce apoptosis.

  • Inhibits human acute myeloid leukemia cell K562 with IC50s of 24.99 μM (24 h), 6.61 μM (48 h), and 12.10 μM (72 h).
  • Inhibits human acute myeloid leukemia cell Jurkat with IC50s of 27.16 μM (24 h), 15.51 μM (48 h), and 3.94 μM (72 h).
  • Cytotoxicity against human MCF7, NCI-H460, and SF-268 cells (GI50 > 10 μg/mL).

Catalog No. 50-003-41265 Supplier Medchemexpress LLC Supplier No. HY129592100MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

p-Tolylmaleimide (compound 9) is a naphthalimide derivative with cytotoxic effects on cancer cells. It can arrest the cell cycle of human acute myeloid leukemia cells K562 in the sub-G0/G1 phase and induce apoptosis.

  • Inhibits human acute myeloid leukemia cell K562 with IC50s of 24.99 μM (24 h), 6.61 μM (48 h), and 12.10 μM (72 h).
  • Inhibits human acute myeloid leukemia cell Jurkat with IC50s of 27.16 μM (24 h), 15.51 μM (48 h), and 3.94 μM (72 h).
  • Cytotoxicity against human MCF7, NCI-H460, and SF-268 cells (GI50 > 10 μg/mL).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.